Abstract
Background: The purpose of this study was to assess the morbidity and determine survival after ureteral decompression in patients with advanced nonurologic malignancies.
Methods: Between June 1988 and June 1993 78 patients were referred to a single surgeon for ureteral decompression. Records were analyzed in relation to primary diagnosis, early and late complications, number of hospitalizations, and survival after decompression.
Results: Seventy-two percent of patients initially underwent decompression endoscopically, and 28% required percutaneous nephrostomy placement at initial decompression. Complications occurred in 50% of patients and most commonly included infection (29%), stent obstruction and encrustation (28%), and gross hematuria (9%). The median survival for all patients after the first decompression procedure was 6.8 months (range 0.5–46.1), with an actuarial survival rate at 1 year of 55% and at 3 years of 30%. The eight patients with gastric/pancreatic cancer survived a median of just 1.4 months after decompression (range 0.77–11.8), with a 1-year actuarial survival rate of 12.5% and 3-year actuarial survival of 0%, which was significantly worse when compared with all other groups taken together or individually (p<0.03).
Conclusions: Ureteral decompression procedures in patients with advanced cancer can be an important component of palliative care but are associated with significant morbidity (50%) in patients whose median survival is <7 months. The role of ureteral decompression in patients with advanced gastric and pancreatic cancer is limited.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Russo P. Urologic emergencies. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds.Cancer: principles and practice of oncology. 4th ed. Philadelphia: JB Lippincott, 1992:2161–3.
Holden S, McPhee M, Grabstald H. The rationale of urinary diversion in cancer patients.J Urol 1979;121:19–21.
Brin EN, Schiff M, Weiss RM. Palliative urinary diversion for pelvic malignancy.J Urol 1979;113:619–22.
Zadra JA, Jewett MA, Keresteci AG, et al. Nonoperative urinary diversion for malignant ureteral obstruction.Cancer 1987;60:1353.
Montana GS, Fowler WC. Carcinoma of the cervix: analysis of bladder and rectal radiation dose and complications.Int J Radiat Oncol Biol Phys 1989;16:95.
Norman RW, Mack FG, Awad SA, et al. Acute renal failure secondary to bilateral ureteral obstruction: review of 50 cases.Can Med Assoc 1982;127:601.
Rose BS, Ragosin R, LaRosa JL, et al. Pyelosinus extravasation and urinoma associated with malignancy.Urology 1988;31:349.
Kaplan E, Meier P. Nonparametric estimation from incomplete observations.J Am Stat Assoc 1953;53:457.
Peto R, Pike MC, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples.Br J Cancer 1977;35:1.
Cronan JJ. Contemporary concepts in imaging urinary obstruction.Radiol Clin North Am 1991;29:527.
Kearney GP, Docimo SG, Doyle CJ, et al. Cutaneous ureterostomy in adults.Urology 1992;40:1.
Zimskind PD, Fetter TR, Wilkerson JL. Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically.J Urol 1967;97:840.
Saltzman B. Ureteral stents: indications, variations, and complications.Urol Clin North Am 1988;15:481.
Mardis HK, Kroeger MR, Donovan JM, et al. Comparative evaluation of materials used for internal ureteral stents.J Endourol 1993;7:2.
Chiou RK, Chang WY, Horan J. Ureteral obstruction associated with prostate cancer. The outcome after percutaneous nephrostomy.J Urol 143:957.
Soper JT, Blaszczyk TM, Oke E, et al. Percutaneous nephrostomy in gynecologic oncology patients.Am J Obstet Gynecol 1988;158:1126.
Lee PH, Khauli RB, Baker S, et al. Prognostic and therapeutic observations of manifestations in the genitourinary tract of adenocarcinoma of the colon and rectum.Surg Gynecol Obstet 1989;169:511.
Reloux P, Weiser M, Piccart M, et al. Ureteral obstruction in patients with breast cancer.Cancer 1988;61:1904.
Goodwin WE, Carey WC, Woolf W. Percutaneous trocar (needle) nephrostomy in hydronephrosis.JAMA 1955;57:891–4.
Pollard SG, Macfarlane R. Symptoms arising from double-j ureteral stents.J Urol 1988;139:37–8.
Zandra JA, Jewett MAS, Keresteci AG, Rankin JT. Nonoperative urinary diversion for malignant ureteral obstruction.Cancer 1987;60:1353–7.
Evans PA, Nisbet AP, Saxton HM. Antegrade ureteral stents in malignant disease.J Intervent Radiol 1988;3:9–13.
Hoe JWM, Tung K, Tan EC. Reevaluation of indications for percutaneous nephrostomy and interventional uroradiological procedures in pelvic malignancy.Br J Urol 1993;71:469–72.
Barton DP, Morse SS, Cavanagh D, et al. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.Obstet Gynecol 1992;80:805–11.
Franco G, DeDominicis C, Laurenti C, et al. The incidence of post-operative urinary tract infection in patients with ureteric stents.Br J Urol 1990;65:10–2.
Blumenthal D, Russo P, Orr J. Unilateral ureteral obstruction in a patient with acute leukemia.Urol Radiol 1990;12:61.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Donat, S.M., Russo, P. Ureteral decompression in advanced nonurologic malignancies. Annals of Surgical Oncology 3, 393–399 (1996). https://doi.org/10.1007/BF02305670
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02305670